Literature DB >> 15813186

Macrolides with promotive activity of monocyte to macrophage differentiation.

Kiminari Yoshida, Toshiaki Sunazuka, Kenichiro Nagai, Akihiro Sugawara, Achim Cho, Tohru Nagamitsu, Yoshihiro Harigaya, Kazuhiko Otoguro, Kiyoko S Akagawa, Satoshi Omura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15813186     DOI: 10.1038/ja.2005.11

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  5 in total

Review 1.  Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.

Authors:  P M Bartold; A H du Bois; S Gannon; D R Haynes; R S Hirsch
Journal:  Inflammopharmacology       Date:  2013-02-28       Impact factor: 4.473

2.  Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model.

Authors:  Akihiro Sugawara; Hideaki Shima; Akito Sueki; Tomoyasu Hirose; Hidehito Matsui; Hayato Nakano; Hideaki Hanaki; Kiyoko S Akagawa; Satoshi Ōmura; Toshiaki Sunazuka
Journal:  J Antibiot (Tokyo)       Date:  2015-09-30       Impact factor: 2.649

3.  Erythromycin derivatives inhibit HIV-1 replication in macrophages through modulation of MAPK activity to induce small isoforms of C/EBPbeta.

Authors:  Iwao Komuro; Toshiaki Sunazuka; Kiyoko S Akagawa; Yasuko Yokota; Aikichi Iwamoto; Satoshi Omura
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

4.  EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.

Authors:  Ying Ji Li; Arata Azuma; Jiro Usuki; Shinji Abe; Kuniko Matsuda; Toshiaki Sunazuka; Takako Shimizu; Yukiyo Hirata; Hirofumi Inagaki; Tomoyuki Kawada; Satoru Takahashi; Shoji Kudoh; Satoshi Omura
Journal:  Respir Res       Date:  2006-01-27

Review 5.  State of progress in treating cystic fibrosis respiratory disease.

Authors:  Patrick A Flume; Donald R Van Devanter
Journal:  BMC Med       Date:  2012-08-10       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.